China Digital X-Ray Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

China Digital X-Ray Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

China's digital x-ray market was valued at USD 551.24 million in 2021 and is projected to register a CAGR of 9.1% during the forecast period (2022-2027).

The COVID pandemic had an adverse effect on the digital x-ray market growth in the country. The National government-mandated response to COVID-19 in China was a declared state of emergency and a state-wide lockdown in 2020. This severely constrained the use of digital imaging for a variety of disease diagnoses across numerous healthcare facilities, which in turn constrained the expansion of the Chinese market for digital x-ray systems. Similar to this, a study published in the Journal of Orthopedic Surgery and Research in February 2021 under the title "Full recovery of elective orthopedic surgery in the age of COVID-19: an 8-month retrospective cohort study" found that elective orthopedic procedures at a hospital in Shanghai, China, have fully recovered from the COVID-19 pandemic, and the new normalcy created during the post-pandemic period has helped this region cope well. The number of specified procedures carried out in the first three months was only 31.72% of the same period in 2019, but in the next five months, the ratio rose to 97.47%. Thus, the above-mentioned factors impacted the growth of China’s digital x-ray throughout the pandemic phase.

Demand for emerging markets industry the developing nations, potential applications, technological advancements, and increasing adoption of digital radiograph systems are the prime growth drivers of the digital x-ray devices market. Major players are engaged in a variety of strategic activities. These include of product launches, collaborations, partnerships, mergers, and acquisitions. For instance, Koninklijke Philips NV and Zhejiang University inked a contract in June 2021 to upgrade and expand the infrastructure for ultrasound, image-guided therapy, monitoring analytics, and therapeutic care solutions in China. Additionally, AstraZeneca and Geneseeq Technology Inc. strategically worked together in April 2021 to launch the Bio-Diagnostic Innovation Center in China. In order to develop an integrated and patient-centric approach to illness diagnosis, treatment, and rehabilitation for cancer patients, the collaboration also entails the establishment of a clinical diagnostics laboratory. In China, clinics are also involved in a lot of awareness-raising activities. For instance, the Parkway Pantai China clinic network sought to increase public knowledge of radiography in September 2020. During the projection period, initiatives like these are anticipated to drive market growth. However, the high cost of the equipment is expected to hinder the market growth.

Key Market TrendsComputed Radiography Segment is Expected to Hold a Significant Market Share Over the Forecast Period

Digital x-ray film is being replaced by computed radiography technology. Imaging plates are available in several system classes (image quality), with varying necessary exposure times, and are utilized using the same radiographic examination procedures and techniques as film. The rising incidence of chronic diseases like cancer, the rising demand for efficient diagnostic imaging techniques, and the adoption of cutting-edge technology are some of the key factors influencing the computed radiography devices market in China. The predicted number of breast cancer cases in China in 2020 was 416,371, according to the Globocan 2020 report published by the International Agency for Research on Cancer. Additionally, according to the same survey, 815,563 instances of lung cancer were anticipated to occur in 2020. According to a review article 'Use of radiographic features in COVID-19 diagnosis: Challenges and perspectives, published in July 2020 in the Journal of the Chinese Medical Association, radiographic technologies, and tools, such as computed tomography (CT) and chest x-ray, were used for initial screening and follow-up for the COVID-19 virus, from which the tools provided detailed diagnosis with specific pathologic features for staging and treatment arrangement. The need for imaging and diagnostics is being driven by the rise in the use of computed radiography to diagnose a variety of disorders. There are various strategic initiatives such as product launches being undertaken by the major players. For instance, Koninklijke Philips NV and Zhejiang University inked a contract in June 2021 to upgrade and expand the infrastructure for ultrasound, image-guided therapy, monitoring analytics, and therapeutic care solutions in China. Therefore, the developments mentioned above are further expected to improve the market growth in this segment.

Competitive Landscape

China digital x-ray market is moderately competitive and consists of several major players. Some of the companies that are currently dominating the market are Canon Medical Systems, Siemens Healthineers AG, GE Healthcare, Fujifilm Holdings Corporation, and Koninklijke Philips NV among others.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

Please note: This publisher does offer titles that are created upon receipt of order. If you are purchasing a PDF Email Delivery option above, the report will take approximately 2 business days to prepare and deliver.